N/A N=338 Rapid Acceleration for Diagnostics in Underserved Populations: Home Testing
COVID-19
Primary: Number of Participants Who Reported Not Following Social Distancing Guidelines — 164 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=49 Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers
Non-small Cell Lung Cancer · EGFR-mutant Lung Cancers
Primary: Osimertinib Maximum Tolerated Dose (MTD) (Phase I) — 80 mg
Phase 2 N=10 Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept
Hereditary Hemorrhagic Telangiectasia
Primary: Change in Lesion Area of Treated Telangiectasia. — -6; -8 mm^2
N/A N=2 Stimulation for Colonic Motility
Neurogenic Bowel Dysfunction
Primary: Compare Changes in Number of Interventions Used to Complete Bowel Routine, Including Electrical Rectal Stimulation (Treatment) Versus Mechanical Rectal Distension…
N/A N=136 BD MiniDraw™ Capillary System Clinical Equivalence Study
Healthy · Disease, Chronic · Acute Disease
Primary: Chemistry Analytes [Albumin (ALB) and Total Protein (TP)] in Serum Measured Using the Silica Clot Activator for Serum Samples — 3.746; 3.787; 6.77; 6.83 g/dL
Phase 2 N=136 Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer
Advanced or Inoperable Gastric Cancer
Primary: Progression Free Survival (PFS) by Investigator Assessment — 3.7; 2.1 Months — p== 0.1428
N/A N=9 Vascular Inflammation and Anti-inflammatory Supplements After Adverse Pregnancy Outcomes
Pre-Eclampsia · Pre-Term · Intrauterine Growth Restriction
Primary: Blood Pressure (mmHg) — 122; 116 mmHg
N/A N=67 Translational Development of Photon-counting CT Imaging
Cancer · Inflammatory Disease · Vascular Diseases
Primary: Mean Difference in Diagnostic Image Quality Grading of Photon Counting CT vs Conventional CT Images. — 0.947368421 score on a scale
Phase 2 N=282 Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy
Painful Diabetic Peripheral Neuropathy
Primary: Change in Mean Average Pain Intensity (NRS) — -1.21; -1.03 units on a scale
N/A N=130 RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction
Full-thickness Skin Defects · Degloving Injuries · Crush Injuries
Primary: Incidence of Treatment Area Healing — 30; 34 Treatment Areas — p=.005
Phase 4 N=32 Magnetic Resonance Imaging of the Effect of Music Listening on Brain Activity Under Anesthesia
Healthy
Primary: Blood Oxygen Level Dependent (BOLD) Response to Sensory Stimuli During Sedation — 0.04; 0.01 arbitrary units — p=<0.001
N/A N=15 Glaucoma Surgery Using the ViaLase Laser System
Glaucoma · Glaucoma, Open-Angle
Primary: Mean IOP — 12.7 mmHg
Phase 2 N=19 Phase II Study of Alternating Sunitinib and Temsirolimus
Metastatic Renal Cell Carcinoma
Primary: Progression Free Survival — 8.8 Months
Phase 2 N=18 Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis
Primary: Number of Subjects With Serious and Non Serious Adverse Events — 1; 1; 1; 1 Participants
N/A N=68 Stepped-Care Telehealth for Distress in Cancer Survivors
Anxiety · Depressive Symptoms · Sleep Disturbance
Primary: Feasibility of Study Intervention Measured by Retention — 16; 12; 32 Participants — p=0.29